Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer
Gunasekharan, Vignesh, Lin, Hao-Kuen, Marczyk, Michal, Rios-Hoyo, Alejandro, Campos, Gerson Espinoza, Shan, Naing Lin, Ahmed, Mostafa, Umlauf, Sheila, Gareiss, Peter, Raaisa, Raaisa, Williams, Richard, Cardone, Rebecca, Siebel, Stephan, Kibbey, Richard, Surovtseva, Yulia V., Pusztai, Lajos
Published in Breast cancer research and treatment (01.12.2024)
Published in Breast cancer research and treatment (01.12.2024)
Get full text
Journal Article
Abstract PO3-25-08: Artificial Intelligence-based screening of small molecule inhibitors of phosphoenolpyruvate carboxykinase 2 (PCK2), a novel cancer therapeutic target
Hoyo, Alejandro Rios, Shan, Naing Lin, Lin, Hao-Kuen, Campos, Gerson Espinoza, Ahmed, Mostafa, Umlauf, Sheila, Cardone, Rebecca, Surovtseva, Yulia V., Gunasekharan, Vignesh, pusztai, Lajos
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article